NV40:FRA
Cellectar Biosciences Inc
€0.25
0.00%
(0.00) 1D
Jun 24, 8:08:19 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NV40...
Mkt. cap
17.30M
Volume
0.00
52-wk high
€0.25
52-wk low
€0.25
No. of employees
11
Mkt. cap
17.30M
Volume
0.00
52-wk high
€0.25
52-wk low
€0.25
No. of employees
11
News stories
From web sources and news partners
Investing.com UK
·
37 minutes ago
Cellectar plans Phase 3 trial, regulatory filing for WM treatment By Investing.com
Yahoo Finance
·
45 minutes ago
Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia
Stock Titan
·
45 minutes ago
A cancer drug produced responses in 87.5% of patients resistant to a prior cancer treatment
https://www.dars.gov.et/
·
2 months ago
CLRB Q1 2026 Earnings: EPS Beat Narrowed Losses but Stock Declines - EPS Growth Rate
About Cellectar Biosciences Inc
CEO-
Employees11
Founded1996
HeadquartersFlorham Park, New Jersey, United States
SectorBiotechnology
Websitecellectar.com